Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
72 studies found for:    "Dementia With Lewy Bodies"
Show Display Options
Rank Status Study
21 Recruiting Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia With Lewy Bodies
Conditions: Dementia With Lewy Bodies;   REM Sleep Behavior Disorder
Interventions: Drug: Nelotanserin;   Drug: Placebo
22 Recruiting Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia
Conditions: Lewy Body Dementia;   Visual Hallucinations
Interventions: Drug: Nelotanserin;   Drug: Placebo
23 Completed Diagnostic of Lewy Body Dementia by Combining Scintigraphy (SPECT) Using a Specific Transporter and Magnetic Resonance Imaging (MRI)
Condition: Lewy Body Dementia
Intervention: Procedure: Single photon emission computed tomography and Magnetic Resonance Imaging
24 Unknown  Construction-LBD (Constructional Apraxia in Alzheimer's Disease (AD) and Lewy Body's Dementia (LBD))
Conditions: Alzheimer's Disease;   Lewy Body's Dementia
Interventions: Other: Rey figure test;   Other: MRI
25 Recruiting LESCOD: "Lewy Body Screening in Cognitive Disorders"
Conditions: Alzheimer Disease;   Lewy Body Disease
Intervention: Other: LeSCoD scale
26 Completed Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia
Conditions: Lewy Body Dementia;   Non-DLB Dementia;   Alzheimer’s;   Vascular Dementia
Intervention: Drug: DatSCAN
27 Completed A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)
Conditions: Dementia With Lewy Bodies;   Alzheimer's Disease;   Parkinson's Disease
Interventions: Drug: 18F-AV-133;   Drug: 18F-AV-45
28 Enrolling by invitation Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Conditions: Lewy Body Dementia;   Dementia With Lewy Bodies;   Parkinson's Disease Dementia;   Visual Hallucinations;   REM Sleep Behavior Disorder
Intervention: Drug: Nelotanserin
29 Recruiting Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
Conditions: Alzheimer's Disease;   Dementia With Lewy Bodies;   Parkinson's Disease Dementia
Interventions: Drug: RVT-101 35 mg;   Drug: Placebo
30 Completed Oculomotor Testing in the Differential Diagnosis of Dementia
Conditions: Lewy Body Disease;   Alzheimer's Disease
Intervention: Other: oculomotor measurements
31 Not yet recruiting Co-LEsions in Alzheimer Disease and Related Disorders
Conditions: Alzheimer's Disease;   Cerebrovascular Disease;   Lewy Body Disease
Intervention: Radiation: SPECT-DaTscan
32 Enrolling by invitation DaTSCAN Imaging in Aging and Neurodegenerative Disease
Conditions: Dementia;   Parkinsonism;   Mild Cognitive Impairment;   REM Sleep Behavior Disorder
Interventions: Drug: I-123 Ioflupane solution injection prior to SPECT scan (DaTscan);   Device: Single photon emission computed tomography (SPECT) scan
33 Recruiting Study for the Early Diagnosis of Parkinson's Disease
Condition: Parkinson's Disease, Idiopathic
Intervention:
34 Recruiting Natural History Study of Synucleinopathies
Condition: Patients With Synucleinopathies
Intervention:
35 Recruiting Safety, Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition
Condition: Disinhibition Syndrome
Interventions: Drug: AVP-786;   Drug: Placebo
36 Recruiting Genetic Characterization of Movement Disorders and Dementias
Conditions: Ataxia;   Dystonia;   Parkinson's Disease;   Amyotrophic Lateral Sclerosis;   Corticobasal Degeneration;   Multiple System Atrophy;   Alzheimer's Disease;   Lewy Body Dementia;   Parkinson Disease-Dementia;   Dentatorubral-pallidoluysian Atrophy;   Creutzfeldt-Jakob Disease and Fatal Familial Insomnia;   Fragile X-associated Tremor/Ataxia Syndrome;   Krabbe's Disease;   Niemann-Pick Disease, Type C;   Neuronal Ceroid Lipofuscinosis
Intervention:
37 Completed Nilotinib in Cognitively Impaired Parkinson Disease Patients 001
Conditions: Parkinson's Disease;   Parkinson's Disease Dementia;   Diffuse Lewy Body Disease
Intervention: Drug: Nilotinib
38 Not yet recruiting EEG-cholinergic Index and Clinical Response to Treatment With Cholinesterase Inhibitors
Condition: Alzheimer´s Disease
Intervention:
39 Completed Research of Biomarkers in Parkinson Disease
Conditions: Parkinson Disease;   Multiple System Atrophy;   Progressive Supranuclear Palsy;   Huntington Disease;   Dystonia;   Diffuse Lewy Body Disease
Intervention:
40 Recruiting Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease
Conditions: Parkinson Disease;   Multiple System Atrophy;   REM Sleep Behavior Disorder;   Pure Autonomic Failure;   Dementia With Lewy Bodies
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.